Product description

Botulinum toxin type A

Indication: Glabella Lines (Approved in KR, US, Canada, on-going registration in EU), 
Post Stroke Upper Limb Spasticity (Approved in KR), 
Crow's feet (Approved in KR), Blepharospasm (Approved in KR)

- NabotaTM is the only 900kDa neurotoxin approved in US and to be registered in EU since BotoxTM
- It has proven efficacy & safety with the large-scale global clinical studies for more than 2,000 subjects in the US and Europe for the first time by Korean botulinum toxin.
- It is produced with a patented technology for purity, minimizing the presence of impurities

Read more

Specifications

Categories Biopharmaceuticals

More products from Daewoong Pharmaceutical Co.,Ltd

View all our products (11)

Products from other suppliers